Deletion notice for DIPROSONE OV cream
For Fellows and Trainees
For Health Professionals
Posted 12 months ago
Merck Sharp & Dohme (MSD) wishes to advise that it will discontinue the supply of DIPROSONE® OV (optimised vehicle) betamethasone dipropionate cream tubes (30 grams) in Australia from November 2019.
MSD has faced long standing formulation manufacturing challenges with this product and the decision to discontinue this DIPROSONE OV cream world-wide has become final in recent time.
MSD’s regulatory team is working to inform this discontinuation to the Therapeutic Goods Administration (TGA). MSD is also is in the process of developing appropriate communication to prescribers and pharmacists, which will include a list of alternative therapies.